Peptides are starting to move back into the conversation., After years of restriction under the FDAs 503A Category 2 list, were now seeing momentum toward re evaluation and potential reintroduction peptides #fda #longevity #glp1 #precisionmedicine #compounding Katherine Erickson FDA Removes 12 Peptides from 503A Category 2 : r us_pharmacies Last week @fda sends out clarification on who can and cannot compound #glp1 like #tirzeaptide and #semaglutide and this week ProRx 503b shuts down GLP 1 compounding while @martymakary is photographed holding bootleg #